CURRICULUM VITAE - IVAR SØNBØ KRISTIANSEN.
Publications in peer-reviewed journals
91.
Nexøe J, Kristiansen IS, Gyrd-Hansen D, Nielsen JB. Influence of number needed to
treat, costs and outcome on preferences for a preventive drug. Family Practice 2005;
22: 126-31.
92.
Lofthus CM, Cappelen I, Osnes EK, Falch JA, Kristiansen IS, Medhus AW,
Nordsletten L, Meyer HE. Local and national electronic databases in Norway
demonstrate a varying degree of validity. J Clin Epidemiol 2005; 58: 280-85.
93.
Kristiansen IS, Olsen JA. Foreldreløse legemidler og helseløse pasienter. Tidsskr Nor
Lægeforen 2005; 125: 992.
94.
Christensen PM, Brixen K, Kristiansen IS. Cost-effectiveness of alendronate in the
prevention of osteoporotic fractures in Danish women. Basic & Clinical
Pharmacology & Toxicology 2005; 96: 387-96.
95.
Halvorsen PA, Kristiansen IS. Decisions on drug therapies by number needed to treat.
A randomized trial. Archiv Int Med 2005; 165: 1140-46.
96.
Kristiansen IS, Christensen PM, Gyrd-Hansen-D. Benign breast disease and breast
cancer. New Engl J Med 2005; 353: 1856-7.
97.
Kildemoes HW, Christiansen T, Gyrd-Hansen D, Kristiansen IS, Andersen M. The
impact of population ageing on future Danish drug expenditure. Health Policy 2006;
75: 298-311.
98.
Dybdahl T, Søndergaard J, Kragstrup J, Kristiansen IS, Andersen M. General
practitioners' adoption of new drugs and previous prescribing of drugs belonging to
the same therapeutic class: A pharmacoepidemiological study. Br J Clin Pharmacol
2005; 60: 526-33.
99.
Kildemoes HW, Kristiansen IS. Response to an optimistic viewpoint. Int J Technol
Assess Health Care 2005; 31: 414-22.
100. Selmer R, Halvorsen S, Myhre KI, Wisløff TF, Kristiansen IS. Cost-effectiveness of
primary percutaneous coronary intervention versus thrombolytic therapy for acute
myocardial infarction. Scand Cardiovasc J 2005; 39: 276-85.
101. Nexøe J, Kristiansen IS. Risikokommunikation i relation til sundhedsfremme og
forebyggelse. Ugeskr Læger 2005; 167: 4673.
102. Kristiansen IS, Bjerrum L. Medikamentel behandling af raske. Lægemiddelkataloget
2005-2006. København: Dansk Lægemiddelinformation, 2005.
103. Kristiansen IS. Alkoholskadet statistikk? Tidsskr Nor Lægeforen 2006; 126: 481.
104. Nexøe J, Kristiansen IS. Risikobegreber. Maanedsskr Praktisk Lægegerning 2006;
84:487-97.
105. Christensen PM, Kristiansen IS. Number-Needed-to-treat (NNT) – needs treatment
with care. Basic Clin Pharmacol Toxicol 2006; 99: 12-6.
106. Kristiansen IS, Gyrd-Hansen D, Nexoe J, Nielsen JB. Willingness-to-pay for a
population program aimed at reducing dietary salt in Denmark. Preventive Medicine
2006; 43: 31-5.
107. Wisløff TF, Abrahamsen TG, Bergsaker MAR, Løvoll Ø, Møller P, Pedersen MK,
Kristiansen IS. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV7) vaccine to the Norwegian childhood vaccination program. Vaccine 2006; 24: 569099.
108. Lofthus CM, Osnes EK, Meyer HE, Kristiansen IS, Nordsletten L, Falch JA. Young
patients with hip fracture: A population-based study of bone mass and risk factors for
osteoporosis. Osteop Int 2006; 17: 1666-72.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
Wisløff TF, Abrahamsen TG, Bergsaker MAR, Løvoll Ø, Kristiansen IS. Vaksinering
– er det verdt pengene? Tidsskr Nor Lægeforen 2006; 126: 2670-3.
Levorsen A, Kristiansen IS, Aasland OG. Physicians’ attitudes to and experience with
increased use of individual reimbursement versus general reimbursement of new
important pharmaceuticals (abstract). Value in Health 2006; 9 (6): A218.
Kristiansen IS, Gyrd-Hansen D. Communicating treatment effectiveness in the
context of chronic disease processes. Expert Rev Pharmacoeconomics Outcomes Res
2006; 6: 673-9.
Johansen-K, Kristiansen-IS, Lønning-PE, Naume-B, Norum-J, Olsen-JA, Wist-E. Ny
medikamentell behandling av brystkreft Adjuvant behandling med trastuzumab ved
tidlig stadium av brystkreft - en helseøkonomisk analyse Rapport fra
Kunnskapssenteret Nr 18–2006. Oslo: Nasjonalt kunnskapssenter for helsetjenesten
2006. ISBN 82-8121-112-1. 39 s. Metodevurdering
Kristiansen IS, Gyrd-Hansen D. Prioritering og helse – bør det innføres en makspris
på leveår? Tidsskr Nor Lægeforen 2007; 127: 54-57.
Killie MK, Kjeldsen-Kragh-J, Husebekk A, Skogen B, Olsen-JA, Kristiansen IS.
Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia.
Brit J Gynecol 2007; 2007;114: 588-595
Gyrd-Hansen D, Halvorsen PA, Kristiansen IS. Willingness-to-pay for a statistical
life in the times of a pandemic. Health Econ 2007 Apr 3; [Epub ahead of print]
Uhlig T, Loge JH, Kristiansen IS, Kvien TK. Quantification of reduced health-related
quality of life in patients with rheumatoid arthritis compared to the general
population. J Reumatology 2007 (E-pub ahead of print)
Kristiansen IS, Gyrd-Hansen D, Halvorsen PA. Influenza pandemic: Perception of
risk and individual precautions in a general population. Cross-sectional study. BMC
Public Health 2007 Apr 2; 7: 48..
Dahl-R, Gyrd-Hansen-D, Kristiansen-IS, Nexøe-J, Nielsen-JB. Can postponement of
an adverse outcome be used to present risk reductions to a lay audience? A population
survey. BMC Medical Informatics and Decision Making 2007, 7:8
Halvorsen-PA, Selmer-R, Kristiansen-IS. Different ways to describe the benefits of
risk-reducing treatments: a randomized trial. Ann Int Med 2007; 146: 848-56.
Nexøe J, Halvorsen PA, Kristiansen IS. GPs’ critique of the risk concept – valid or
not? Scand J Publ Health 2007;
Gyrd-Hansen D, Kristiansen IS. Preferences for ‘life-saving’ programmes: small for
all or gambling for the prize? Health Economics 2007 (E-pub ahead of print)
Zebis-LR, Christensen-TD, Kristiansen IS, Hjortdal VE. Amiodarone cost
effectiveness in preventing atrial fibrillation after coronary artery bypass graft
surgery. Ann thorac surg 2008; 85: 28-32.
Kristiansen IS. Prioritering er mer enn å ordne køen. Tidsskr Nor Lægeforen 2007;
127: 2278.
Romøren M, Hussein F, Steen TW, Velauthapillai M, Sundby J, Hjortdahl P,
Kristiansen IS. Costs and health consequences of chlamydia management strategies
among pregnant women in sub-Saharan Africa. BMJ Sexually Transmitted Infections
2007 (E-pub ahead of print).
Aaserud M, Kristiansen, IS, Neilson A Norum J, Sørbye H, Aas E, Klemp Gjertsen
M. Helseøkonomisk evaluering av bevacizumab ved metastatisk colorectal cancer. .
Oslo: Nasjonalt kunnskapssenter for helsetjenesten 2007. ISBN 978-82-8121-186-5.
74 s.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
137
138
139.
Kristiansen IS. To pasienter i sengen eller én i korridoren? Tidsskr Nor Lægeforen
2008; 128: 16.
Kristiansen IS. How up-to-date are Cochrane reviews? Lancet 2008; 371: 384.
Isacson-D, Bingefors-K, Kristiansen-IS. Fluctuating functions related to quality
of life in advanced Parkinson disease: effects of duodenal levodopa infusion. Acta
Neurol Scand 2008; (E-publish ahead of print).
Bergman-A, Hjelmgren-J, Ortqvist-A, Wisloff-T, Kristiansen-IS, Hogberg-LD,
Persson-KM, Persson-U. Cost-effectiveness analysis of a universal vaccination
programmeme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in
Sweden. Scand J Infect Dis 2008 (Epub ahead of print).
Sørensen L, Gyrd-Hansen D, Kristiansen IS, Nexøe J, Nielsen JB. Laypersons'
understanding of relative risk reductions: a randomised cross-sectional study. BMC
Med Inform Decis Mak 2008 17 July; 8: 31.
Levorsen-A, Kristiansen-IS, Aasland-OG. Legers erfaring med individuell refusjon av
legemidler. Tidsskr Nor Lægeforen 2008; 128: 1829-32.
Støvring-H, Gyrd-Hansen D, Kristiansen-IS, Nielsen-JB. Communicating
effectiveness of intervention for chronic diseases: what single format can replace
comprehensive nformation? BMC Med Inform Decis Mak 2008 Jun 19: 25.
Fuglenes-D, Øyan-P, Kristiansen IS. Obstetricians’ choice of cesarean delivery in
ambiguous cases: is it influenced by risk attitude or fear of complaints and litigation?
Am J Gyn Obst 2008 (e-Pub ahead of print).
Wisløff T, Nordheim OF, Halvorsen S, Selmer RM, Kristiansen IS. Kostnader og
leveårsgevinster ved medikamentell primærforebygging av hjertekarsykdom. Rapport
Nr 34-2008. Oslo: Nasjonalt kunnskapssenter for helsetjenesten, 2008. ISBN 978-828121-237-4.
Håheim LL, Fretheim A, Brørs O, Kjeldsen SE, Kristiansen IS, Madsen S, Njølstad I,
Norheim OF, Ose L, Svilaas A, Flottorp S, Thürmer H. Primærforebygging av hjerteog karsykdom, med hovedvekt på medikamentelle tiltak. Rapport nr 20-2008. Oslo:
Nasjonalt kunnskapssenter for helsetjenesten, 2008. ISBN 978-82-8121-143-8.
Kristiansen-IS, Bingefors-C, Nyholm-D, Isacson-D. Short-term cost and health
consequences of duodenal levodopa infusion in advanced Parkinson’s disease in
Sweden: an exploratory study. Appl Health Econ Health Policy 2009 (accepted)
Kristiansen IS, Elstein AS, Gyrd-Hansen D, Kildemoes HW, Nielsen JB. Radiation
from mobile phone systems: is it perceived as a threat to people’s health?
Bioelectromagnetics 2009: (accepted)
Hamidi-V et al. Cost effectiveness of open versus laparoscopic living donor
nephrectomy. Transplantation (accepted).
Other publications
17.
Romøren-M, Hussein-F, Steen-TW, Velauthapillai-M, Sundby-J, Hjortdahl-P,
Kristiansen-IS. Costs and health consequences of chlamydia management strategies
among pregnant women in sub-Saharan Africa (Techical Report). HERO working
paper 2007: 10. Oslo: Health Economics Research Programme, University of Oslo,
2007.
18.
Wisløff T, Halvorsen S, Selmer RS, Kristiansen. Norwegian Cardiovascular Disease
Model (NorCad) – a simulation model for estimating health benefits and cost
consequences of cardiovascular interventions. Oslo: Norwegian Knowledge Centre
for Health Services, 2008. ISBN 978-82-8121-220-6.
38.
Kristiansen IS. Helseøkonomi. I Larsen, Alvik, Hagestad og Nylenna:
Samfunnsmedisin. Oslo: Gyldendal, 2008.
36.
Kristiansen IS. Evidence based medicine – time for asking critical questions? ISPOR
Conncetions. The Official News & Technical Journal Of The International Society of
Pharmacoeconomics And Outcomes Research. 2007; 13: 4-7
38.
Kristiansen IS. Spare på skillingen? Dagens Medisin nr 24/2007, 1. november, side
17.
39.
Kristiansen IS. EBM - en sikker kilde til sannhet? Dagens Medisin 25/2007, 8.
november, s. 15.
40..
Kristiansen IS. Budsjettkutt eller overtrekksoppgjør? Dagens Medisin 13. mars 2008,
side 18.
Teaching
Have supervised in the order of 30 master theses in Tromsø, Copenhagen, Odense and Oslo
Have (co-)supervised 7 PhD candidates
Is currently supervising 6 PhD candidates
Teaching the following courses:
HMM4401 – Health and Medicine (UiO)
HMM4301 - Optimal allocation of health care resources and economic evaluation of health
care technologies
HMM4103 – Research Design and qualitative methods
HØKON4102 – Økonomisk evaluering